| ORIGINAL ARTICLE |
|
| Year : 2018 | Volume
: 14
| Issue : 57 | Page : 458-464 |
|
|
Naringenin protects against 1-methyl-4-phenylpyridinium- induced neuroinflammation and resulting reactive oxygen species production in SH-SY5Y cell line: An in Vitro model of parkinson's disease
Sugumar Mani1, Sathiya Sekar2, Saravana Babu Chidambaram3, Murugan Sevanan4
1 Research and Development Centre, Bharathiar University, Coimbatore, Tamil Nadu, India
2 Department of Biotechnology, Dr. M. G. R. Educational and Research Institute University, Chennai, Tamil Nadu, India
3 Department of Pharmacology, JSS College of Pharmacy, JSS University, Mysore, Karnataka, India
4 Department of Biotechnology, Karunya Institute of Technology and Sciences, Coimbatore, Tamil Nadu, India
Correspondence Address:
Murugan Sevanan
Department of Biotechnology, Karunya Institute of Technology and Sciences, Karunya Nagar, Coimbatore - 641 114, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/pm.pm_23_18
|
|
|
Background: Parkinson's disease is a progressive neurodegenerative disorder which affects 1% of the population worldwide. It is well known that 1-methyl-4-phenylpyridinium (MPP+) selectively and potentially inhibit Complex I of the mitochondrial electron transport chain. This inactivation leads to the generation of reactive oxygen species (ROS), which in turn damage neurons. In addition, neuroinflammation plays a major role in neurodegeneration processes. Objective: In the present study, the effect of naringenin (NGN), on MPP+-induced neuroinflammation and ROS generation in SH-SY5Y cells were investigated. Materials and Methods: Cells were pretreated with (0.1% dimethyl sulfoxide) or NGN (25, 50, and 100 μm/mL) for 24 h, and then induced with 1 mM MPP+ for 15 min. Following overnight incubation, cells were harvested for ROS staining, gene expression of apoptotic markers such as B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax), inflammatory markers such as tumor necrosis factor-alpha (TNF-α), and nuclear factor-κB (NF-κB) and protein expression of neuronal markers such as dopamine transporter (DAT), tyrosine hydroxylase (TH), and α-synuclein (SYN). Results: In this study, NGN exhibited oxidative protection by decreasing ROS generation which is evidenced through significant regulation of oxidative stress markers. Likewise, NGN decreased TNF-α, Bax, and NF-κB and increased Bcl-2 gene expressions in MPP+-induced SH-SY5Y cells compared to normal SH-SY5Y cells. Further, NGN significantly and dose-dependently decreased SYN and increased DAT and TH levels in MPP+-induced SH-SY5Y cells in comparison to the normal cells. Conclusion: The results obtained from the present study revealed that NGN has the potential to encounter MPP+-induced dopaminergic degeneration through regulating ROS generation and neuroinflammation.
Abbreviations used: TNF-α: Tumor Necrosis Factor alpha; NF-κB: Nuclear factor; SYN-α: synuclein; NGN: Naringenin; MPP+: 1-methyl-4-phenylpyridinium; MPTP: 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine; PD-Parkinson's disease; DCFH-DA: 2',7' - dichlorofluorescin diacetate; SOD: Superoxide dismutase; NO: Nitric oxide; MDA: Malondialdehyde; DAT: Dopamine transporter; TH: Tyrosine hydroxylase; ANOVA: Analysis of variance; SEM: Standard error of the mean; RT-PCR: Reverse transcriptase-polymerase chain reaction; BSA: Bovine serum albumin; PBS: Phosphate buffered saline; TBST: Tris-Buffered saline with Tween; RNA: Ribonucleic acid.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
